IDH1 and central nervous system cancer: The findings of our research demonstrated a significant elevation of LINC00475 in IDH1 wild-type gliomas compared to IDH1-mutant gliomas, thereby corroborating a positive correlation between high LINC00475 levels and poor outcome in glioma patients.